» Articles » PMID: 30636900

Developmental Exposure to Di-(2-ethylhexyl) Phthalate Induces Cerebellar Granule Cell Apoptosis Via the PI3K/AKT Signaling Pathway

Overview
Journal Exp Neurobiol
Specialty Neurology
Date 2019 Jan 15
PMID 30636900
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Di-(2-ethylhexyl) phthalate (DEHP) is an ubiquitous environmental contaminant because of its extensive use in plastics and its persistence. As an environmental endocrine disruptor, it is suspected to interfere with neurodevelopment in people. However, evidence of the effects of maternal DEHP exposure on cerebellar development in offspring is scarce. The objective of this study was to investigate maternal exposure to DEHP and its effect on apoptosis of cerebellar granule cells (CGCs) and related mechanisms. Pregnant Wistar rats were administrated DEHP (0, 30, 300 and 750 mg/kg/d) by gavage from gestational day (GD) 0 to postnatal day (PN) 21. Primary CGCs were also exposed to mono-(2-ethylhexyl) phthalate (MEHP), the main metabolite of DEHP, for 24 h with concentrations of 0, 25, 100 and 250 µM. The CGCs of male offspring from 300 and 750 mg/kg/d DEHP exposure groups showed significantly increased apoptosis. In addition, the PI3K/AKT signaling pathway was inhibited in the male offspring of the 300 and 750 mg/kg/d DEHP exposure groups. However, effects on female pups were not obvious. Apoptosis was also elevated and the PI3K/AKT signaling pathway was inhibited after primary CGCs were exposed to MEHP. Furthermore, apoptosis was reduced after treatment with the PI3K/AKT signaling pathway activator, insulin-like growth factor (IGF) 1, and increased after treatment with LY294002, an inhibitor of the PI3K/AKT signaling pathway. These results suggested that maternal DEHP exposure induced apoptosis in the CGCs of male pups via the PI3K/AKT signaling pathway, and the apoptosis could be rescued by IGF1 and aggravated by LY294002.

Citing Articles

White matter microstructural integrity mediates associations between prenatal endocrine-disrupting chemicals exposure and intelligence in adolescents.

Wang S, Wen H, Huang F, Sun C, Huang C, Wang S Neuroimage Clin. 2025; 45:103758.

PMID: 39983551 PMC: 11889738. DOI: 10.1016/j.nicl.2025.103758.


Mitigating effect of ferulic acid on di-(2-ethylhexyl) phthalate-induced neurocognitive dysfunction in male rats with a comprehensive in silico survey.

Khalifa M, Fayed R, Ahmed Y, Sedik A, El-Dydamony N, Khalil H Naunyn Schmiedebergs Arch Pharmacol. 2023; 397(5):3493-3512.

PMID: 37966574 PMC: 11074231. DOI: 10.1007/s00210-023-02831-9.


Interrelationships among growth hormone, thyroid function, and endocrine-disrupting chemicals on the susceptibility to attention-deficit/hyperactivity disorder.

Wang L, Huang Y, Chou W, Lee S, Chang H, Chen C Eur Child Adolesc Psychiatry. 2022; 32(8):1391-1401.

PMID: 35119524 DOI: 10.1007/s00787-021-01886-4.


Effects of Mono-2-ethylhexyl Phthalate on the Neural Transmission of PNs in Drosophila Antennal Lobe.

Liu X, Yang J, Gan Z, Wang H, Hu Z, Liu J Neurotox Res. 2021; 39(5):1430-1439.

PMID: 34191265 DOI: 10.1007/s12640-021-00386-2.


Prenatal Exposure to Endocrine-Disrupting Chemicals and Subsequent Brain Structure Changes Revealed by Voxel-Based Morphometry and Generalized Q-Sampling MRI.

Shen C, Weng J, Tsai J, Su P, Chou M, Wang S Int J Environ Res Public Health. 2021; 18(9).

PMID: 33946254 PMC: 8125311. DOI: 10.3390/ijerph18094798.


References
1.
Wolin E . PI3K/Akt/mTOR pathway inhibitors in the therapy of pancreatic neuroendocrine tumors. Cancer Lett. 2013; 335(1):1-8. DOI: 10.1016/j.canlet.2013.02.016. View

2.
Barakat R, Lin P, Park C, Best-Popescu C, Bakry H, Abosalem M . Prenatal Exposure to DEHP Induces Neuronal Degeneration and Neurobehavioral Abnormalities in Adult Male Mice. Toxicol Sci. 2018; 164(2):439-452. PMC: 6061835. DOI: 10.1093/toxsci/kfy103. View

3.
Buckley J, Palmieri R, Matuszewski J, Herring A, Baird D, Hartmann K . Consumer product exposures associated with urinary phthalate levels in pregnant women. J Expo Sci Environ Epidemiol. 2012; 22(5):468-75. PMC: 3439834. DOI: 10.1038/jes.2012.33. View

4.
Martini M, De Santis M, Braccini L, Gulluni F, Hirsch E . PI3K/AKT signaling pathway and cancer: an updated review. Ann Med. 2014; 46(6):372-83. DOI: 10.3109/07853890.2014.912836. View

5.
Kim E, Suresh M . Role of PI3K/Akt signaling in memory CD8 T cell differentiation. Front Immunol. 2013; 4:20. PMC: 3561661. DOI: 10.3389/fimmu.2013.00020. View